| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Revenue | $1.21B | -2.7% |
| Cost of Revenue | $815.6M | -7.5% |
| Gross Profit | $390.2M | +9.2% |
| R&D Expense | $50.6M | +5.3% |
| SG&A Expense | $270.2M | -2.4% |
| Operating Income | $64.8M | +6.6% |
| Pre-tax Income | $61.9M | +1.8% |
| Income Tax | -$6.4M | -138.6% |
| Net Income | $64.5M |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $164.6M | +58.8% |
| Accounts Receivable | $42.2M | +31.5% |
| Current Assets | $422.5M | +9.2% |
| Total Assets | $550.1M | +7.7% |
| Current Liabilities | $279.3M | -5.0% |
| Total Liabilities | $283.5M | -5.6% |
| Stockholders' Equity | $246.2M | +27.1% |
| Line Item | 2024-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $78.2M | +44.4% |
| Capital Expenditures | $18.9M | -13.8% |
| Investing Cash Flow | -$748K | +97.8% |
| Financing Cash Flow | -$17.2M | -9.0% |
| Free Cash Flow | $59.3M | +84.2% |
| +59.2% |
| EPS (Basic) | $2.55 | +60.4% |
| EPS (Diluted) | $2.54 | +60.8% |